Anebulo Pharmaceuticals Statistics
Total Valuation
ANEB has a market cap or net worth of 16,314. The enterprise value is -9.03 million.
| Market Cap | 16,314 |
| Enterprise Value | -9.03M |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ANEB has 40.78 million shares outstanding. The number of shares has increased by 55.97% in one year.
| Current Share Class | 40.78M |
| Shares Outstanding | 40.78M |
| Shares Change (YoY) | +55.97% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 40.84% |
| Owned by Institutions (%) | n/a |
| Float | 24.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.00 |
| P/TBV Ratio | 0.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.24
| Current Ratio | 6.24 |
| Quick Ratio | 6.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -30.60 |
Financial Efficiency
Return on equity (ROE) is -69.69% and return on invested capital (ROIC) is -49.69%.
| Return on Equity (ROE) | -69.69% |
| Return on Assets (ROA) | -45.04% |
| Return on Invested Capital (ROIC) | -49.69% |
| Return on Capital Employed (ROCE) | -114.70% |
| Weighted Average Cost of Capital (WACC) | -6.15% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.99% in the last 52 weeks. The beta is -1.89, so ANEB's price volatility has been lower than the market average.
| Beta (5Y) | -1.89 |
| 52-Week Price Change | -99.99% |
| 50-Day Moving Average | 0.32 |
| 200-Day Moving Average | 0.59 |
| Relative Strength Index (RSI) | 11.90 |
| Average Volume (20 Days) | 255 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1,463.70 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.10M |
| Pretax Income | -7.98M |
| Net Income | -7.98M |
| EBITDA | n/a |
| EBIT | -9.10M |
| Earnings Per Share (EPS) | -0.19 |
Balance Sheet
The company has 9.04 million in cash and no debt, with a net cash position of 9.04 million or 0.22 per share.
| Cash & Cash Equivalents | 9.04M |
| Total Debt | n/a |
| Net Cash | 9.04M |
| Net Cash Per Share | 0.22 |
| Equity (Book Value) | 7.94M |
| Book Value Per Share | 0.19 |
| Working Capital | 7.79M |
Cash Flow
| Operating Cash Flow | -5.84M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ANEB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -55.97% |
| Shareholder Yield | -55.97% |
| Earnings Yield | -48,907.37% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |